FDA approves first GMO flu vaccine containing reprogrammed insect virus

Friday, February 08, 2013 by: Jonathan Benson, staff writer


(NaturalNews) A new vaccine for influenza has hit the market, and it is the  first ever to contain genetically-modified (GM) proteins derived from insect  cells. According to reports, the U.S. Food and Drug Administration (FDA)  recently approved the vaccine, known as Flublok, which contains recombinant DNA  technology and an insect virus known as baculovirus that is purported to help  facilitate the more rapid production of vaccines.

According to Flublok’s  package insert, the vaccine is trivalent, which means it contains GM proteins  from three different flu strains. The vaccine’s manufacturer, Protein Sciences  Corporation (PSC), explains that Flublok is produced by extracting cells from  the fall armyworm, a type of caterpillar, and genetically altering them to  produce large amounts of hemagglutinin, a flu virus protein that enables the flu  virus itself to enter the body quickly.
So rather than have to produce  vaccines the “traditional” way using egg cultures, vaccine manufacturers will  now have the ability to rapidly produce large batches of flu virus protein using  GMOs, which is sure to increase profits for the vaccine industry. But it is also  sure to lead to all sorts of serious side effects, including the deadly nerve  disease Guillain-Barre Syndrome (GSB), which is listed on the shot as a  potential side effect.
“If Guillain-Barre Syndrome (GBS) has occurred  within six weeks of receipt of a prior influenza vaccine, the decision to give  Flublock should be based on careful consideration of the potential benefits and  risks,” explains a section of the vaccine’s literature entitled “Warnings and  Precautions.” Other potential side effects include allergic reactions,  respiratory infections, headaches, fatigue, altered immunocompetence,  rhinorrhea, and myalgia.
According to clinical data provided by PSC in  Flublok’s package insert, two study participants actually died during trials of  the vaccine. But the  company still insists Flublok is safe and effective, and that it is about 45  percent effective against all strains of influenza in circulation, rather than  just one or two strains.

flu_shot cartoon aug 11

FDA also approves flu vaccine containing dog kidney cells

Back in  November, the FDA also approved a new flu vaccine known as Flucelvax that is  actually made using dog kidney cells. A product of pharmaceutical giant  Novartis, Flucelvax also does away with the egg cultures, and can similarly be  produced much more rapidly than traditional flu  vaccines, which means vaccine companies can have it ready and waiting should the  federal government declare a pandemic.
Like Flublok, Flucelvax was made  possible because of a $1 billion, taxpayer-funded grant given by the U.S. Department of Health and Human Services (HHS) to the vaccine industry  back in 2006 to develop new manufacturing methods for vaccines. The ultimate  goal is to be able to quickly manufacture hundreds of millions of vaccines for  rapid distribution.
Meanwhile, there are reportedly two other GMO flu  vaccines currently under development. One of them, which is being produced by  Novavax, will utilize “bits of genetic material grown in caterpillar cells  called ‘virus-like particles’ that mimic a flu virus,” according to Reuters.
Learn more:  http://www.naturalnews.com/039013_flu_vaccine_insect_virus_GMOs.html#ixzz2KMbOxWFG


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s